Tyra Biosciences Inc (TYRA)
$20.09
Performance
- $20.09$21.50$20.09
0.02%
Downside
Day's Volatility :6.58%
Upside
6.56%
- $10.38$22.20$20.09
48.33%
Downside
52 Weeks Volatility :53.24%
Upside
9.5%
Returns
| Period | Tyra Biosciences Inc | Index (Russel 2000) |
|---|---|---|
3 Months | 29.87% | 0.0% |
6 Months | 57.14% | 0.0% |
1 Year | 42.11% | 0.0% |
3 Years | -21.73% | -20.2% |
Highlights
Market Capitalization | 1.1B |
Book Value | $7.43 |
Earnings Per Share (EPS) | -1.69 |
Wall Street Target Price | 25.2 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -16.66% |
Return On Equity TTM | -23.63% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -87.5M |
Diluted Eps TTM | -1.69 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.71 |
EPS Estimate Next Year | -2.09 |
EPS Estimate Current Quarter | -0.45 |
EPS Estimate Next Quarter | -0.43 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 25.44%
Technicals Summary
Sell
Neutral
Buy
Tyra Biosciences Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Tyra Biosciences Inc | 28.8% | 57.14% | 42.11% | -21.73% | -21.73% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Tyra Biosciences Inc | NA | NA | NA | -1.71 | -0.24 | -0.17 | NA | 7.43 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Tyra Biosciences Inc | Buy | $1.1B | -21.73% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Tyra Biosciences Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 19.5%
Institutional Holdings
RA Capital Management, LLC
19.83%Boxer Capital LLC
12.27%Bvf Inc
8.87%Canaan Partners XI LLC
8.39%Nextech Invest AG
7.72%FMR Inc
7.57%
Company Information
tyra biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Organization | Tyra Biosciences Inc |
Employees | 49 |
CEO | Dr. Todd Harris Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$20.09
-1.28%
Keyarch Acquisition Corp
$20.09
-1.28%
Connexa Sports Technologies Inc
$20.09
-1.28%
Us Value Etf
$20.09
-1.28%
First Wave Biopharma Inc
$20.09
-1.28%
Global X Msci Next Emerging
$20.09
-1.28%
Fat Projects Acquisition Corp
$20.09
-1.28%
Capital Link Global Fintech
$20.09
-1.28%
Applied Uv Inc
$20.09
-1.28%